These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanism of vascular relaxation by thaligrisine: functional and binding assays. Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849 [TBL] [Abstract][Full Text] [Related]
3. Interaction of calmodulin and calcium antagonists with [3H]diltiazem and [3H]nitrendipine binding sites. Schaeffer P; Lugnier C; Stoclet JC J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S102-3. PubMed ID: 2468847 [TBL] [Abstract][Full Text] [Related]
4. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel. Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380 [TBL] [Abstract][Full Text] [Related]
5. Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta. Ivorra MD; Lugnier C; Catret M; Anselmi E; Cortes D; D'Ocon P Br J Pharmacol; 1993 Jun; 109(2):502-9. PubMed ID: 8358549 [TBL] [Abstract][Full Text] [Related]
6. Lactamimides: a novel chemical class of calcium antagonists with diltiazem-like properties. Palfreyman MG; Dudley MW; Cheng HC; Mir AK; Yamada S; Roeske WR; Obata T; Yamamura HI Biochem Pharmacol; 1989 Aug; 38(15):2459-65. PubMed ID: 2757648 [TBL] [Abstract][Full Text] [Related]
7. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes. Suzuki T; Kurosawa H; Naito K; Otsuka M; Ohashi M; Takaiti O Eur J Pharmacol; 1991 Mar; 194(2-3):195-200. PubMed ID: 2060600 [TBL] [Abstract][Full Text] [Related]
8. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes. Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806 [TBL] [Abstract][Full Text] [Related]
9. Calcium channel receptor binding studies for diltiazem and its major metabolites: functional correlation to inhibition of portal vein myogenic activity. Schoemaker H; Hicks PE; Langer SZ J Cardiovasc Pharmacol; 1987 Feb; 9(2):173-80. PubMed ID: 2435995 [TBL] [Abstract][Full Text] [Related]
10. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex. Schoemaker H; Langer SZ J Pharmacol Exp Ther; 1989 Feb; 248(2):710-5. PubMed ID: 2537412 [TBL] [Abstract][Full Text] [Related]
11. Relationships between structure and vascular activity in a series of benzylisoquinolines. Chulia S; Ivorra MD; Martinez S; Elorriaga M; Valiente M; Noguera MA; Lugnier C; Advenier C; D'Ocon P Br J Pharmacol; 1997 Oct; 122(3):409-16. PubMed ID: 9351495 [TBL] [Abstract][Full Text] [Related]
12. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex. Schoemaker H; Langer SZ Eur J Pharmacol; 1985 May; 111(2):273-7. PubMed ID: 2410283 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine. Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512 [TBL] [Abstract][Full Text] [Related]
14. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes. Boles RG; Yamamura HI; Schoemaker H; Roeske WR J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261 [TBL] [Abstract][Full Text] [Related]
15. The binding of the calcium channel blocker, bepridil, to calmodulin. Itoh H; Tanaka T; Mitani Y; Hidaka H Biochem Pharmacol; 1986 Jan; 35(2):217-20. PubMed ID: 3484629 [TBL] [Abstract][Full Text] [Related]
16. The interaction of the NK1 receptor antagonist CP-96,345 with L-type calcium channels and its functional consequences. Guard S; Boyle SJ; Tang KW; Watling KJ; McKnight AT; Woodruff GN Br J Pharmacol; 1993 Sep; 110(1):385-91. PubMed ID: 7693284 [TBL] [Abstract][Full Text] [Related]
17. Polyamines allosterically modulate [3H]nitrendipine binding to the voltage-sensitive calcium channel in rat brain. Schoemaker H Eur J Pharmacol; 1992 Feb; 225(2):167-9. PubMed ID: 1312941 [TBL] [Abstract][Full Text] [Related]
18. Calmodulin antagonistic action of new 1,5-benzothiazepines derived from diltiazem. Suzuki T; Ohashi M; Takaiti O; Harigaya S Arzneimittelforschung; 1994 Jan; 44(1):3-6. PubMed ID: 8135875 [TBL] [Abstract][Full Text] [Related]
19. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle. Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393 [TBL] [Abstract][Full Text] [Related]